Yinuo Pang

5PUBLICATIONS
34CO-AUTHORS
PharmacogenomicsGlycoconjugatesAutoimmunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jun 12, 2024
Population Pharmacokinetic and Exposure-Response Modeling to Inform Risankizumab Dose Selection in Patients With Ulcerative Colitis.

Neha Thakre, Aline Goebel, Insa Winzenborg

|Mar 20, 2024
An anti-TNF-glucocorticoid receptor modulator antibody-drug conjugate is efficacious against immune-mediated inflammatory diseases.

Michael J McPherson, Adrian D Hobson, Axel Hernandez

|Jan 24, 2024
Risankizumab: Mechanism of action, clinical and translational science.

Yinuo Pang, Ronilda D'Cunha, Insa Winzenborg

|Sep 30, 2022
Population Pharmacokinetics and Exposure-Response Analyses for Risankizumab in Patients with Active Psoriatic Arthritis.

Neha Thakre, Ronilda D'Cunha, Aline Goebel

Pageof 1